|
|
???tair.name??? >
???browser.page.title.author???
|
"bang yj"???jsp.browse.items-by-author.description???
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2019-12-01 |
Liposomal irinotecan in metastatic pancreatic adenocarcinoma in Asian patients: Subgroup analysis of the NAPOLI-1 study
|
Bang, YJ;Li, CP;Lee, KH;Chiu, CF;Park, JO;Shan, YS;Kim, JS;Chen, JS;Shim, HJ;Rau, KM;Choi, HJ;Oh, DY;Belanger, B;Chen, LT |
| 國家衛生研究院 |
2019-10 |
Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II
|
Chua, YJ;Pavlakis, N;Sjoquist, KM;Martin, AJ;Tsobanis, E;Yip, S;Bang, YJ;Alcindor, T;O'Callaghan, CJ;Bekaii-Saab, TS;Grothey, A;Chen, LT;Simes, J;Zalcberg, JR;Goldstein, D;Komatsu, Y;Machida, N;Esaki, T;Hara, H;Shitara, K |
| 國家衛生研究院 |
2016-12 |
Efficacy and safety of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02, BAX-2398) in patients with metastatic pancreatic cancer in Asia: A subgroup analysis of the phase 3 NAPOLI-1 Study
|
Chen, LT;Li, CP;Chiu, CF;Shan, YS;Park, JO;Chen, JS;Kim, JS;Rau, KM;de Jong, F;Pipas, M;Belanger, B;Wang, E;Lee, KH;Bang, YJ |
| 國家衛生研究院 |
2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad
|
Denlinger, CS;Sym, SJ;Bendell, JC;Alsina, M;Watkins, D;Chao, Y;Cubillo, A;Kunz, PL;Sun, WJ;Baeksgaard, L;Chen, LT;Horgan, K;Frye, S;Kudia, AJ;McDonagh, CF;Czibere, AG;Moyo, VM;Chibaudel, B;Bang, YJ |
Showing items 1-4 of 4 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
